Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOKYO Pharma Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2023 | Q2 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 08/14/2023 | Q4 2023 | N/A | -$0.17 | N/A | N/A | $0 |
| 08/14/2023 | Q3 2023 | N/A | -$0.17 | N/A | N/A | $0 |
| 09/28/2022 | Q2 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 08/15/2022 | Q1 2023 | N/A | -$0.11 | N/A | N/A | $0 |
| 08/15/2022 | Q4 2022 | N/A | -$0.00 | N/A | N/A | $0 |
| 08/15/2022 | Q3 2022 | N/A | -$0.07 | N/A | N/A | $0 |
| 09/29/2021 | Q2 2022 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/29/2021 | Q1 2022 | N/A | -$0.07 | N/A | N/A | $0 |
| 03/30/2021 | Q4 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/30/2020 | Q3 2021 | N/A | -$0.10 | N/A | N/A | $0 |
| 09/29/2020 | Q2 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/29/2020 | Q1 2021 | N/A | -$0.02 | N/A | N/A | $0 |
| 03/30/2020 | Q4 2020 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/30/2019 | Q3 2020 | N/A | $0.01 | N/A | N/A | $178 |
| 09/29/2019 | Q2 2020 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/29/2019 | Q1 2020 | N/A | -$0.08 | N/A | N/A | $0 |
| 03/30/2019 | Q4 2019 | N/A | -$0.16 | N/A | N/A | $0 |
| 12/30/2018 | Q3 2019 | N/A | -$0.16 | N/A | N/A | $0 |
| 09/29/2018 | Q2 2019 | N/A | -$0.07 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
OKYO Pharma Limited Earnings: FAQ's
OKYO Pharma Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based offlast year's report dates.
The conference call for OKYO Pharma Limited's latest earnings report can be listened to online.
The conference call transcript for OKYO Pharma Limited's latest earnings report can be read online.
OKYO Pharma Limited (:OKYO) has a recorded net income of $-16,825.OKYO Pharma Limited has generated $-0.0006 earnings per share over the last four quarters.
OKYO Pharma Limited (:OKYO) has a price-to-earnings ratio of -2633.45 and price/earnings-to-growth ratio is -26.33.